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Abstract
The current study intends to investigate i) the incidence of herpes viruses including Herpes Simplex Virus type-1 (HSV-1),
Cytomegalovirus (CMV) and Human Herpes Virus -6, -7, -8 (HHV6, HHV7, HHV8) in two biological samples, bronchoalveolar
lavage fluid (BALF) and lung tissue biopsy, in different forms of pulmonary fibrosis, and ii) the induction of molecular
pathways involved in fibrosis by herpesvirus infection in primary cell cultures. PCR was employed for the detection of CMV,
HHV6-8 and HSV-1 DNA in lung specimens (4 controls and 11 IPF specimens) and BALF pellet [6 controls and 20 fibrotic
Idiopathic Intestitial Pneumonias (f-IIPs) samples: 13 idiopathic pulmonary fibrosis (IPF) and 7 nonspecific idiopathic
interstitial pneumonia (NSIP)] samples. Among all herpesviruses tested, HSV-1 was detected in 1/11 (9%) specimens from IPF
lung tissue and in 2/20 (10%) samples of f-IIPs BALF whereas the control group was negative. Primary cell cultures from
BALF of patients with IPF and healthy controls were infected in vitro with wild-type HSV-1 virus and Real Time PCR was
employed for the detection of gene transcription of specific axes implicated in lung fibrosis. Primary cell cultures were
permissive to HSV-1, resulting in an upregulation of the fibrotic growth factors TGFb1 and FGF, the angiogenetic markers
SDF1a, SDF1b, VEGF, FGF and the regulators of tissue wound healing MMP9 and CCR7. Downregulation was noted for the
CXCR4 and MMP2 genes, while a different response has been detected in healthy donors regarding the expression of the
aforementioned markers. These results implicate for the first time the HSV-1 with Fibrotic Idiopathic Interstitial Pneumonias
since the virus presented similar incidence in two different biological samples.
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Introduction
Idiopathic pulmonary fibrosis (IPF) is perhaps the most
pernicious and enigmatic form of a greater problem of lung
fibrogenesis with no proven effective therapy other than lung
transplantation and associated with a median patient survival of
three years [1]. The pathogenesis of IPF remains unknown.
Epithelial injury, fibroblast activation and repetitive cycles of
injury and abnormal repair are almost certainly key events [2].
While the pathogenesis remains unclear, the spatial and temporal
variance of fibrotic lesions suggests a repeated stimulus causing
lung injury over the course of the disease [3].
Several studies have implicated chronic viral infection as a cause
of ongoing epithelial injury in IPF and therefore an important
cofactor, either initiating or exacerbating the disease [4]. Previous
studies have shown the presence of Epstein-Barr virus (EBV),
Cytomegalovirus, and human herpesviruses (HHV) 7 and 8 in
patients with IPF [5–7]. It should be noted that other studies did
not find an association between herpesviral infection and IPF, and
it is not clear whether these discrepancies represent geographical
variation or technical differences [8,9].
Animal models support the hypothesis linking herpesvirus
infections with specific T helper 2 (Th2) cytokine profile and
alternative activation of macrophages as co-factors for the
development of pulmonary fibrosis [4,10–12]. The identified
mechanisms contributing to lytic virus-induced exacerbation of
fibrosis include Th2 bias, persistent reactivation, alternative
activation of macrophages, and fibrocyte recruitment [3,12–15].
Moreover, novel data indicate that herpesvirus promotes epithe-
lial-mesenchymal transition, a crucial process which occurs during
fibrosis [3,16].
Finally, recent research suggests potential gammaherpesvirus-
mediated mechanisms for the increased fibrosis involving alveolar
epithelial cells (AECs) and macrophages [17]. Latently infected
AECs also produce higher levels of cysteinyl leukotrienes and the
potent pro-fibrotic cytokine transforming growth factor (TGF)-b1
through alteration of Cux1/Wnt signalling [17,18].
This study aimed to investigate the incidence of a wide range of
herpesviruses, including HSV-1, CMV and the most recently
discovered HHV6, HHV7 and HHV8, in two different biological
samples, bronchoalveolar lavage fluid (BALF) and lung tissue, in
different forms of pulmonary fibrosis. The hypothesis tested was
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e27800that a herpes virus infection, through induction of molecular
pathways, could promote the fibrotic pathway. The results support
the hypothesis only for the HSV-1.
Results
Incidence of Herpesviruses in BALF and lung tissue
All lung tissue biopsy samples and all BALF specimens (patients
and controls) were negative for the presence of CMV, HHV7 and
HHV8 DNA. HSV-1 was detected in 1 out of 11 (9%) specimens
from the IPF lung tissue group while 2 out of 20 (10%) samples of
fibrotic Idiopathic Intestitial Pneumonias (f-IIPs) BALF were also
positive for the same virus. Lung tissues biopsies or BALF control
specimens proved to be PCR-negative for HSV-1. HHV6 DNA
was also not detected in lung tissue biopsies of patients and
controls. However, 3 out of 6 (3/6, 50%) of the controls and 9 out
of 20 (45%) f-IIPs patients BALF were found positive for the same
virus. Representative examples of herpesvirus-positive samples are
shown in Figure 1 while the cumulative results are presented in
Table S1.
Primary cell culture
The permissiveness of the primary cultures by HSV-1 was
evaluated by immunofluorescence. After in vitro infection with a
wild-type HSV-1 strain, macrophages expressed all classes of
HSV-1 genes such as ICP0 (immediate early), ICP8 (early) and gG
(late) genes, during the course of the infection, as observed by
fluorescence microscopy (Figure 2A). In addition, the HSV-1
infected primary cell cultures tested positive for the genomic DNA
of the virus, using PCR methodology, while the mock infected
primary cell cultures tested negative for the presence of viral
genome (Figure 2B). These results demonstrate that pulmonary
macrophages are permissive to the virus and can serve as hosts in
lung tissue.
Gene expression
We next sought to address whether infection of macrophages by
HSV-1 might cause alterations in the expression pattern of fibrotic
growth factors [Transforming Growth Factor b1 (TGFb1) and
Fibroblast Growth Factor (FGF)], angiogenetic markers [Stromal
cell-Derived Factor 1a and 1b (SDF-1a, SDF-1b), C-X-C
chemokine receptor type 4 (CXCR4), Vascular Endothelial
Growth Factor (VEGF)], innate immunity factors [Toll-Like
Receptor 3, 8, 9 (TLR3, TLR8, TLR9)] and regulators of tissue
wound healing [Matrix Metallopeptidase 2, 9 (MMP2, MMP9)
and C-C chemokine receptor type 7 (CCR7)] with ligands
Chemokine (C-C motif) ligand 21 and 19 (CCL21, CCL19).
Primary cell cultures from fresh BALF were first tested negative for
the presence of HSV-1 DNA and were subsequently divided into
two samples, only one of which was in vitro infected with wild-type
HSV-1. The potential alterations in the expression level of various
genetic axes were assessed by real-time PCR, revealing intriguing
differences among the infected and non-infected cell.
Fibrotic and angiopoietic axis
The fibrotic axis was upregulated in the HSV-1 infected cells of
IPF patients in comparison to the mock cultures, with higher
transcript levels of TGFb1 (mean6SD, 0.005760.001 versus
0.000660.0001) and FGF (mean6SD, 0.03360.066 versus
0.000160.0001) (Table 1). The ratio of the means for the two
culture groups was 9.5 and 330, respectively, favoring the infected
cultures (Figure 3). On the contrary, the fibrogenic axis in the
primary cell cultures of healthy donors was downregulated in the
HSV-1 infected cells compared to the mock cultures with lower
transcript leves of TGFb1 (mean6SD, 0.4860.24 versus
0.5760.31) and FGF (mean6SD, 1.0660.52 versus
64.36639.48) and ratios of the means for the two culture groups
0.84 and 0.02, respectively for the two genes (Table 2), favoring
the mock cultures (Figure 4).
The mRNA levels for SDF-1a, SDF-1b and VEGF of the
angiopoietic axis were increased in the infected cultures of IPF
patients as compared to the mock infected cultures. In particular,
SDF-1a was expressed at higher levels in the infected cultures
(mean6SD, 11.97618.443 versus 1.5662.49 for the mock
infected cultures), with a ratio of means 7.7. In addition, the
VEGF (mean6SD, 0.0460.058 versus 0.060.0) and SDF-1b
(mean6SD, 0.0960.0188 versus 0.060.0) transcript levels were
higher in the infected samples of IPF patients, compared to the
mock infected cultures (Figure 5). Decreased expression levels were
observed for the CXCR4 gene in the infected cultures
(0.000760.00138), compared to the mock infected cultures of
the same group of patients (mean6SD, 0.000760.001 versus
1.5662.49), with a ratio of 0.0002 (Figure 5).
The mRNA levels of the genes involved in the angiopoietic axis
were mainly decreased in the infected cultures of healthy donors
compared to the mock infected cultures. Specifically, SDF-1a was
expressed at lower levels in the infected cultures (mean6SD,
0.6960.67 versus 1.061.0 for the mock infected cultures), with a
ratio of means 0.67. In addition, VEGF (mean6SD, 1.0660.52
versus 64.36639.48) and CXCR4 (mean6SD, 0.7460.31 versus
1.5760.25) transcript levels were lower in the infected samples
compared to the mock infected samples, with ratios of means 0.02
and 0.47 respectively (Figure 4). In contrast, increased expression
Figure 1. Detection of Herpesvirus genomes in BALF and lung
tissue. M; molecular weight marker, +ve; positive control, 2ve;
negative control; b2m: beta-2-microglobulin.
doi:10.1371/journal.pone.0027800.g001
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compared to the mock infected cultures (mean6SD, 1.1261.12
versus 0.960.16), with a ratio of 1.23.
The HSV-1 infected primary cultures from IPF patients showed
lower expression levels in both axis compared to the infected
primary cultures from healthy donors, with the only exception of
SDF-1a (Table 3). Specifically, mRNA transcript levels for SDF-1b
were lower in the cultures from IPF patients compared to the
infected primary cultures from healthy donors with ratio of the
means 0.08 (p=0.348), as well as for CXCR4 with ratio of the
means 0.001 (p=0.568) and VEGF with ratio of the means 0.04
(p=0.05). For the fibrogenic axes genes, the mRNA transcript
levels for TGF-b1 were lower in the cultures from IPF patients
compared to the infected primary cultures from healthy donors
with ratio of the means 0.01 (p=0.439), as well as for FGF with
ratio of the means 0.03 (p=0.463).
The mock infected primary cultures from IPF patients showed
lower expression levels the fibrogenic axes compared to the mock
Figure 2. A. Expression of ICP0 (immediate early), ICP8 (early) and gG (late) HSV-1 proteins in infected macrophages. DAPI (4,6-diamidino-2-
phenylindole). Magnification, 6600 (bars: 5 mM). B. Confirmation of successful HSV-1 infection of cultured lung macrophages by PCR.
doi:10.1371/journal.pone.0027800.g002
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ically, mRNA transcript levels for TGF-b1 were lower in the
cultures from IPF patients compared to the ones from healthy
donors with ratio of the means 0.001 (p=0.240), as well as for
FGF with ratio of the means 0.000001 (p=0.0.501). For the
angiopoietic axes genes, the mRNA transcript levels for SDF-1b
and VEGF were undetectable in the cultures from IPF patients
while for the mock infected primary cultures from healthy donors
were quantifiable with ratio of the means 0.00 (p=0.01 and
p=0.076 respectively). For the SDF-1a and CXCR4 genes, the
transcript levels were higher in the mock infected cultures from
IPF patients, with ratios of the means 1.56 (p=0.758) and 2.29
(p=0.372), respectively compared to the mock infected from
healthy donors.
Regulators of wound healing
Molecular analysis demonstrated elevated transcription levels
for the regulators of wound healing in the HSV-1 infected cultures
of patients with IPF, with the only exception of MMP2. More
specifically, MMP9 transcript levels for the infected samples were
higher compared to the mock (mean6SD, 88.136135.99 versus
12.95616.47) with a ratio of 6.81. CCR7 transcript levels were
also higher for the infected samples (mean6SD, 6.61613.19
versus 0.360.55) with a ratio of 22.31 (Figure 6). The mRNA
levels of MMP2 were lower in the infected samples compared to
the mock infected samples (mean6SD, 0.00360.006 versus
0.00460.007) with a ratio of 0.84.
In contrast, infected cultures from healthy donors showed lower
transcription levels for the regulators of wound healing. MMP2
and MMP9 trancript levels for the infected samples were lower
compared to the mock infected samples (mean6SD, 0.3960.26
versus 0.4160.19 and 0.1760.07 versus 0.3860.14, respectively)
with ratios of means 0.96 and 0.45 respectively. CCR7 transcript
levels were also lower for the infected samples (mean6SD,
0.3160.14 versus 3.9462.72) with a ratio of 0.08 (Figure 4).
The ligands of CCR7, CCL19 (mean6SD, 0.00260.004 versus
0.000560.0007) and CCL21 (mean6SD, 0.000560.0008 versus
0.000260.0002) were overexpressed in the infected samples from
IPF patients with a ratio of 4 and 2.5, respectively, over the
expression of the mock infected samples (Figure 6). This was also
the case for the infected cell cultures from healthy donors, with
higher transcript levels of CCL19 (mean6SD, 17.8368.92 versus
2.0960.87) and CCL21 (mean6SD, 2700062645.75 versus
1500062645.75) compared to the mock infected cultures, with
ratios of means 8.53 and 1.8 respectively.
The HSV-1 infected primary cultures from IPF patients
showed lower expression levels of MMP2 compared to the
infected primary cultures from healthy donors with ratio of the
Figure 3. mRNA expression profile of fibrogenic axis in HSV-1
(n=4) and mock infected (n=4) macrophages from IPF
patients.
doi:10.1371/journal.pone.0027800.g003
Table 1. Expression profile of fibrogenic gene mRNA in infected with recombinant HSV-1 cultures and mock infected cultures
from patients with IPF.
MEANS±SD
Infected
(n=4)
Mock
(n=4)
Ratio of means
(infected/mock) P value
SDF-1a 11.97618.44 1.5662.49 7.7 0.358
SDF-1b 0.0960.019 0.0060.0 - 0.390
CXCR4 0.000760.001 3.667.2 0.0002 0.391
VEGF 0.0460.058 0.0060.00001 - 0.263
TGF-b1 0.00660.001 0.000660.0001 9.5 0.392
FGF 0.03360.07 0.000160.0001 330 0.391
MMP2 0.00360.006 0.00460.007 0.84 0.391
MMP9 88.136135.99 12.95616.47 6.81 0.384
CCR7 6.61613.19 0.360.55 22.3 0.392
CCL19 0.00260.004 0.000560.0007 4 0.447
CCL21 0.000560.0008 0.000260.0002 2.5 0.513
TLR3 0.761.08 0.360.59 2.34 0.619
TLR8 0.060.0 2.6864.22 0 0.294
TLR9 0.060.0 0.060.0 - -
doi:10.1371/journal.pone.0027800.t001
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of the means 0.0001 (p=0.246) and CCL21 with ratio of the
means 10
28 (p=0.001). However, mRNA transcript levels for
MMP9 and CCR7 were higher in the cultures from IPF patients
compared to the infected primary cultures from healthy donors
with ratio of the means 518.41 (p=0.324) and 21.32 (p=0.700),
respectively.
The mock infected primary cultures from IPF patients showed
lower expression levels of MMP2 compared to the mock infected
primary cultures from healthy donors with ratio of the means 0.01
Table 2. Expression profile of fibrogenic gene mRNA in infected with recombinant HSV-1 cultures and mock infected cultures
from healthy donors.
MEANS±SD
Infected
(n=4)
Mock
(n=4)
Ratio of means
(infected/mock) P value
SDF-1a 0.6960.67 1.0061.00 0.67 0.795
SDF-1b 1.1261.12 0.960.16 1.23 0.864
CXCR4 0.7460.31 1.5760.25 0.47 0.101
VEGF 1.0660.52 64.36639.48 0.02 0.184
TGF-b1 0.4860.24 0.5760.31 0.84 0.828
FGF 1.0660.52 64.36639.48 0.02 0.184
MMP2 0.3960.26 0.4160.19 0.96 0.961
MMP9 0.1760.07 0.3860.14 0.45 0.265
CCR7 0.3160.14 3.9462.72 0.08 0.254
CCL19 17.8368.92 2.0960.87 8.53 0.154
CCL21 2700062645.75 1500062645.75 1.8 0.033
TLR3 33.33633.33 21.3368.59 1.56 0.745
TLR8 0.560.16 0.2360.28 0.95 0.939
TLR9 5.0664.29 49.31624.46 0.10 0.149
doi:10.1371/journal.pone.0027800.t002
Figure 4. mRNA expression profile of HSV-1 (n=3) and mock infected (n=3) macrophages from healthy donors.
doi:10.1371/journal.pone.0027800.g004
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0.08 (p=0.074), CCL19 with ratio of the means 0.0002 (p=0.037)
and CCL21 with ratio of the means 10
28 (p=0.001). However,
mRNA transcript levels for MMP9 were higher in the cultures
from IPF patients compared to the mock infected primary cultures
from healthy donors with ratio of the means 34.08 (p=0.254).
Innate immunity axis
We investigated the expression of Toll-like receptors 3, 8 and 9
and discovered higher transcript levels of TLR3 in the infected
cultures from IPF patients, while TLR8 and TLR9 were
undetectable in all the culture samples from IPF patients (data
not shown). Specifically, TLR3 transcript levels were upregulated
in the infected cultures from IPF patients versus the mock infected
cultures (mean6SD, 0.761.9 versus 0.360.6) with a ratio of 2.34.
TLR8 was detected in the mock infected cultures only (mean6SD,
2.6864.23) (Figure 7).
The transcript levels of TLR8 and TLR9 were lower in the
infected cultures from healthy donors compared to the mock
infected cultures (mean6SD, 0.560.16 versus 0.2360.28 and
5.0664.29 versus 49.31624.26 respectively) with ratios of means
0.95 and 0.1 respectively. On the contrary, TLR3 transcript levels
were higher in the infected cultures compared to the mock infected
cultures (mean6SD, 33.33633.33 versus 21.3368.59) with a ratio
of 1.56.
The HSV-1 infected primary cultures from IPF patients showed
lower expression levels of all TLR genes compared to the infected
primary cultures from healthy donors. Specifically, mRNA
transcript levels for TLR3 were lower in the cultures from IPF
patients compared to the infected primary cultures from healthy
donors with ratio of the means 0.02 (p=0.980). While TLR8 and
TLR9 were undetectable in the cultures from IPF patients, in
cultures from healthy donors the transcript levels were significant.
The mock infected primary cultures from IPF patients showed
lower expression levels of TLR3 and TLR9 genes compared to the
mock infected primary cultures from healthy donors. Specifically,
mRNA transcript levels for TLR3 were lower in the cultures from
IPF patients compared to the infected primary cultures from
healthy donors with ratio of the means 0.01 (p=0.0.28), while for
TLR9 the ratio of the means was 0.00 (undetectable in the IPF
cultures, p=0.019). TLR8 transcript levels were higher in the
mock infected IPF cultures compared to the cultures from healthy
donors with ratio of the means 11.65 (p=0.431).
Discussion
The pathogenesis of IPF and other pathologic patterns of
pulmonary fibrosis (non-specific interstitial pneumonia) is still
obscure, as the initiating factors or injuries remain unknown.
Figure 5. mRNA expression levels of angiopoietic axis in HSV-1
(n=4) and mock infected (n=4) macrophages from IPF
patients.
doi:10.1371/journal.pone.0027800.g005
Table 3. Expression profile of mRNA transcript levels of axis in infected with recombinant HSV-1 from IPF patients compared to
healthy donors.
Infected with recombinant HSV-1 cultures
Gene IPF (MEANS) Healthy Donors (MEANS) Ratio of the means (IPF/Donors) p value
SDF-1a 11.97 0.69 17.35 0.348
SDF-1b 0.09 1.12 0.08 0.568
CXCR4 0.00 0.74 0.001 0.349
VEGF 0.04 1.06 0.04 0.05
TGF-b1 0.01 0.48 0.01 0.439
FGF 0.03 1.06 0.03 0.463
MMP2 0.00 0.39 0.01 0.132
MMP9 88.13 0.17 518.41 0.324
CCR7 6.61 0.31 21.32 0.7
CCL19 0.00 17.83 0.0001 0.246
CCL21 0.00 27000 0.00 0.001
TLR3 0.70 33.33 0.02 0.980
TLR8 0.00 0.5 0.00 0.014
TLR9 0.00 5.06 0.00 0.05
doi:10.1371/journal.pone.0027800.t003
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lating nature of fibrosis is poor [19,20]. Our results demonstrated
the ability of Herpes Simplex Virus-type 1 to induce alterations of
lung macrophages in bronchoalveolar lavage fluid that likely
promote fibrotic inflammation and extracellular matrix deposition,
thus, demonstrating a role for HSV-1 in lung fibrosis. First, we
detected the presence of HSV-1 in patients with fibrotic idiopathic
interstitial pneumonias, since the virus presented similar incidence
in two different biological samples, tissue and bronchoalveolar
lavage fluid. Secondly, we found that the presence of HSV-1 can
enhance fibrosis by inducing the transcription of molecular
pathways which promote fibrotic, angiogenetic, wound healing
and innate immunity processes, suggesting a probable role of
infectious factors in the pathogenesis of lung fibrosis. Furthermore,
we identified infected lung macrophages as a source of profibrotic
chemokines. Moreover, supporting the aforementioned findings, a
Table 4. Expression profile of mRNA transcript levels of axis in mock infected with recombinant HSV-1 cultures from IPF patients
compared to healthy donors.
Mock infected cultures
Gene IPF (MEANS) Healthy Donors (MEANS) Ratio of the means (IPF/Donors) p value
SDF-1a 1.56 1 1.56 0.758
SDF-1b 0 0.9 0.00 0.01
CXCR4 3.6 1.57 2.29 0.372
VEGF 0 64.36 0.00 0.076
TGF-b1 0.0006 0.57 0.00 0.240
FGF 0.0001 64.36 0.00 0.501
MMP2 0.004 0.41 0.01 0.051
MMP9 12.95 0.38 34.08 0.254
CCR7 0.3 3.94 0.08 0.074
CCL19 0.0005 2.09 0.00 0.037
CCL21 0.0002 15000 0.00 0.001
TLR3 0.3 21.33 0.01 0.028
TLR8 2.68 0.23 11.65 0.431
TLR9 0 49.31 0.00 0.019
doi:10.1371/journal.pone.0027800.t004
Figure 6. mRNA expression of regulators of wound healing in
HSV-1 (n=4) and mock infected (n=4) macrophages from IPF
patients.
doi:10.1371/journal.pone.0027800.g006
Figure 7. mRNA expression of innate immunity axis in HSV-1
(n=4) and mock infected (n=4) macrophages from IPF
patients.
doi:10.1371/journal.pone.0027800.g007
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healthy controls.
The spatial and temporal variance of fibrotic lesions suggests
that a repeated stimulus, such as a viral infection, causes lung
injury over the course of the disease [19,20]. Viruses are potential
candidates for a role in IPF due to their ubiquitous incidence in
humans and due to the nature of their lifecycle [3]. The most
compelling evidence for a viral co-factor in IPF comes from studies
concerning the association between the gamma-herpesvirus, EBV
[3–9,14], while data from human studies are limited and have
produced conflicting results [5–9]. For instance, latent EBV
infection is most often found in B cells [21]; however, in patients
with IPF, EBV was found in lung tissue, including epithelial cells
[22,23]. Our results are not in disagreement with the aforemen-
tioned studies, as we did not evaluate the incidence of EBV in our
samples. Regarding HHV8 incidence in IPF, previous studies are
in disagreement [5,9]. To note, that the increased frequency of
HHV8 in the lungs of our IPF cohort was particularly important
as HHV8 infection is predominantly found in patients with HIV
infection and Kaposi’s sarcoma [24], and all of the subjects tested
negative for HIV in this study [5]. We also detected HHV6 in a
similar frequency in both patients and controls, however, only in
the BALF. Given the lack of previous data in the literature
regarding this virus and the absence of any statistical difference
between patients and controls, we did not further analyze this
finding. It is obvious, that larger scale studies are needed in order
to detect nonhuman DNA in all forms of pulmonary fibrosis [20].
Animal models support the hypothesis linking herpesvirus
infections with specific T helper 2 (Th2) cytokine profiles and
alternative macrophage activation [5,15,16] as co-factors for the
development of pulmonary fibrosis [4]. Specifically, a murine
gamma-herpesvirus 68 (MHV68) model of pulmonary fibrosis has
enabled the identification of pathogenic cells and mediators that
are believed to be important in human fibrotic disease, and they
have facilitated further exploration of a pathogenic role for viruses
in humans [25].
There is a limited understanding regarding the fibrotic effects of
gamma-herpes viruses on cell types resident or circulating in the
lung, particularly following the clearance of acute lytic infection
[3,26]. The aforementioned findings provide clues concerning the
role for lytic cHV-68 infection in fibrosis, however, most humans
harbor latent herpesviruses throughout their lifetime, and IPF
normally occurs at an advanced age [27].
The present study explored links between IPF and herpesviruses
by examining the potential of the latent infection HSV-1 to
modulate cellular inflammation, fibrosis, angiogenesis and wound
healing in alveolar macrophages in the lung. The virus is
pleotrophic and infects multiple different cells in the lung through
multiple pathways. An increase in fibrotic markers like TGF-b1
and FGF was noted, however, not statistically significant. The fact
that the results of the present study regarding the measurement of
different parameters in mock and infected macrophages did not
reach statistical significance, should be attributed to the small
sample size and to the difficulties of attaining a larger sample size
given the challenge of obtaining and sustaining primary cultures. A
further support of the current study is the healthy controls’
behaviour, showing a different response of macrophages in viral
infection. Given the fact that there have been to date no studies
implicating infectious factors in primary cell cultures from IPF and
NSIP patients resulting in the induction of fibrogenic pathways,
these results should be scrutinized in a qualitative rather than a
quantitative manner.
The mock infected macrophages from IPF patients, showed less,
or at least just as, prone to angiopoietic and fibrogenic pathway
promotion compared to the mock infected macrophages from
healthy donors. This may lead to the hypothesis that macrophages
in IPF have already established equilibrium with the surrounding
fibrotic tissue, thus lacking the need to promote such pathways, or
possibly that these cells have already been altered from the
cytokines circulating the fibrotic lung in a way that they no longer
promote fibrosis and angiopoiesis without further stimuli. This
hypothesis is further supported by the behavior of IPF macro-
phages infected with latent HSV-1, since there was a notable 17-
fold increase of SDF-1a in IPF infected cells compared to the mock
infected healthy macrophages, suggesting that given an infectious
stimuli the macrophages promote at least one component of the
angiopoietic axis. However, the remaining genes of both axis
showed the same expression pattern, suggesting more evidently the
established alterations that the macrophages in IPF have sustained,
thus lacking the amount of excitability promoting fibrogenesis
from infection that the healthy macrophages showed. It is possible
that latent herpesvirus infection may play a role in the
exacerbation of IPF, suggested from the IPF macrophages results,
by promoting specific gene expression but also in the initiative
damage, suggested from the healthy macrophages results.
Focusing on the behavior of IPF macrophages in the pathways
of tissue wound healing and of innate immunity, two pathways
that represent a very active role of these cells, we observed that in
the mock infected cultures IPF macrophages were more prone to
have less effective tissue wound healing cytokine expression
compared to the healthy macrophages. However, given a stimuli
such as herpesvirus infection IPF macrophages showed an
increased tissue wound healing cytokine expression. However,
IPF macrophages were unable to express higher amounts of innate
immunity cytokines compared to the healthy macrophages, even
with an infectious stimuli present, thus further supporting the
hypothesis of established alterations of these cells in the fibrotic
lung.
Our results suggest the virus is associated with two quite
separate pathogenetic processes - in IPF and in NSIP - with a
common process in both being epithelial damage. However, it is
difficult to argue or imply that this virus might drive pathogenesis
in two such rather disease processes. On the other hand, it has
been elegantly suggested that idiopathic UIP and idiopathic NSIP,
sharing a common clinical phenotype, form a spectrum of disease
with a common pathogenesis [28]. It seems likely that the balance
of abnormalities in each of the key wound-healing pathways may
vary between individuals. This variation is likely to be responsible
for the range of clinical, radiological and pathological phenotypes
observed in IPF [28]. Macrophages recruited during lung
inflammation can differentiate into distinct phenotypes with
specialized functions in wound healing, host defence or immune
regulation [14]. Exposure to Th2 cytokines promotes alternative
macrophage activation, the M2 subtype, which stimulates wound
healing and fibrogenesis [26]. It has been found that MMP9 levels
are elevated in patients with pulmonary fibrosis and furthermore,
ablation of the MMP9 gene reduces IL-13-dependent lung
remodelling [29,30]. Moreover, it has been recently demonstrated
by evaluating the pulmonary response to expression of the EBV
lytic transactivator protein Zta, that cells recovered by BAL of
Adv-Zta-treated mice displayed greater than 10-fold elevated
MMP-9 mRNA levels than that in untreated mice [31]. On the
other hand, a modest increase in TGF-b levels has been detected,
suggesting a mechanism for the destruction of the basement
membrane and access of inflammatory cells to the alveolar space
without significant increases in TGF-b activation [31]. We also
found increased MMP9 levels with a parallel increase in TGF-b,i n
accordance with the aforementioned results, showing the effects of
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increase in MMP2 levels. It is of note that TGF-b1, the prototypic
growth factor, demonstrated to be elevated in fibrotic remodeling
in the lungs of patients with IPF didn’t change in the infected
cultures compared to the mock infected cells. Moreover, it has
been recently and elegantly shown that modulation of macrophage
activation following TGFb1 activation have remarkable effects on
collagen deposition, fibrocyte accumulation, BAL cell infiltration
and myofibroblast hyperplasia [32]. In alignment with TGF-b1
behaviour is FGF and MMP-9 expression in controls.
Furthermore, the levels of the chemokines MCP1 and CXCL12
in BAL samples of infected mice during the chronic phase of
infection were detected in IFN-c R2/2 mice during the chronic
phase of infection [33]. In addition, Vannella et al [17] recently
found that MHV68 latently infected alveolar epithelial cells
upregulated the expression of these two chemokines and induced
fibrocyte accumulation in lungs of latent MHV68 infected mice.
The results of the present study are in accordance with these
studies from animal models, showing that after recombinant
infection with HSV-1, both components of SDF-1a are elevated in
patients with IPF. Notably, down-regulation of the specific
receptor CXCR4 was observed in the infected samples, while
expression didn’t alter in healthy controls.
In the present study, increased levels of innate immunity
markers such as TLRs, specifically TLR-3 and chemotactic
chemokines CCR7 and its ligands, CCL19 and CCL21 were
noted. A significant increase at the expression levels of CCL21 has
been detected in the presence of HSV-1 infection in controls.
However, its specific receptor CCR7 didn’t show a similar trend,
while increased levels have been detected in IPF, in agreement
with current literature [34]. CCR7 expression was significantly
raised in different forms of idiopathic interstitial pneumonias,
suggesting that CCR7 positive cells are activated resident
pulmonary fibroblasts [34]. It was recently found that TLR
stimulation led to an increase in MHV68 latency, as evidenced by
an increase in viral genome-positive cells 2 weeks post-in vivo
stimulation by specific TLR ligands [35]. Thus, these data
demonstrate that TLR stimulation can drive MHV68 reactivation
from latency and suggest that periodic pathogen exposure may
contribute to the homeostatic maintenance of chronic gamma-
herpes virus infection through stimulating virus reactivation and
reseeding latency reservoirs [35,36]. These studies indicate that
viral reactivation is essential for the progression of pulmonary
fibrosis; antiviral treatment can therefore prevent progression even
when initiated after the establishment of fibrosis, resulting in
prolonged survival.
This study does not lack limitations since, our results can not
elucidate the exact role of HSV-1 and that this virus might drive
disease progression. It can not be excluded that HSV-1 might have
been a co-factor in the initial damage, setting off the disease
progress, but not necessarily contributing to progression. Rather, a
combination of injuries potentially contributes to the emergence of
pulmonary fibrosis. The trigger that initiates the development of
fibrosis in IPF remains unknown. However, there is increasing
evidence that a wide range of potentially injurious factors may play
a role in the initiation and progression of IPF. Oxidative stress
related or not to smoking attitude, environmental pollutants and
dusts have all been implicated as potential causes of IPF [37]. In
addition, we can not exclude the possibility that this particular
virus is more prone to be carried if there is pre-existing epithelial
damage. Further, experimental work is certainly needed to clarify
the aforementioned findings.
These results of the resent study implicate for the first time, a
role for HSV-1 in fibrotic idiopathic interstitial pneumonias. In
addition, infection with Herpesvirus infection with HSV-1 induced
transcription of molecular pathways that promote fibrotic and
angiogenetic processes, suggesting a possible role in the patho-
genesis of lung fibrosis. The findings of the present study may have
significant implications in developing an antiviral strategy in
patients with IPF and infected with herpesvirus. However, larger
studies are needed to confirm the present results.
Materials and Methods
Ethics Statement
The Ethics Committee of the Medical School of the University
of Crete approved the protocol and all patients and control
subjects provided informed consent in written form.
Patients
Consecutive patients from the Interstitial Lung Disease Unit of
the Department of Thoracic Medicine, University Hospital of
Heraklion, Crete, Greece were enrolled in the study. The
diagnosis was based on internationally accepted clinical and
imaging criteria [1]. In eleven cases, diagnosis was made by video-
assisted thoracoscopic surgery (VATS), where the histologic
diagnosis of usual interstitial pneumonia (UIP) was obtained. In
the remaining cases, the diagnosis was made on the basis of clinical
and high-resolution computed tomography (HRCT) criteria
[1,38].
The bronchoalveolar lavage fluid (BALF) group included 20
patients with idiopathic fibrotic pneumonias (f –IIPs) (Table 5).
The diagnosis was based on internationally accepted clinical and
imaging criteria. The group included 13 patients with IPF and 7
patients with non-specific interstitial pneumonia (NSIP). The
control group included 6 healthy volunteers who were nonsmokers
and able to provide BALF samples.
For the primary cell cultures, bronchoalveolar lavage fluid was
obtained from 4 patients with diagnosed IPF, as described above.
As controls for the primary cell cultures, 3 consecutive never-
smokers from those undergoing bronchoscopy for investigation of
solitary nodule were recruited. These patients had negative
bronchoscopy and were diagnosed as having benign nodule.
Only nonatopic subjects—atopy assessed by skin prick tests—
with no history of respiratory tract infection or IPF exacerbation
12 weeks prior to bronchoscopy were studied. Microbiological
evaluation of BALF was negative in all cases.
The lung specimen group included 11 patients with IPF. The
control group included 4 lung tissue specimens obtained from
macroscopically healthy sites of the lung, from patients ongoing
lobectomy or pneumonectomy and were verified histologically.
Demographics and pulmonary function tests of patients and
controls from the Bronchoalveolar Lavage group and the cell
culture group are shown in Table 5.
Patients were not under steroid and/or immunosuppressive
treatment.
Biological samples and processing
BALF was obtained fresh, from stable IPF patients at room
temperature. After filtering to remove debris, the BALF from each
patient was divided into two samples: one for primary cell culture
while the other was centrifuged at 1,500 rpm and the supernatant
and pellet were stored at 280uC. Lung tissue biopsy specimens
were obtained at 220uC and stored at 280uC.
DNA extraction and PCR amplification
BALF pellet and lung tissue biopsy samples were processed as
follows: Genomic DNA was extracted using the proteinase K
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according to the standard procedures.
PCR reactions for the HHV6, HHV7 and HHV8 assays were
performed using Go Taq Flexi DNA polymerase (Promega, USA).
The set of primers and the PCR amplification conditions for the
viruses HHV6, HHV7 and HHV8 have been previously described
[39]. HSV-1 and CMV were detected by PCR using commercially
available kits (Maxim Biotech, USA) following the manufacturer’s
instructions. The primers specifically amplify target sequences of
HSV-1 DNA polymerase gene. According to the manufacturer, there
is no cross-reaction between HSV-1 and HSV-2. All specimens
were examined for the presence of amplifiable DNA using a set of
primers for the b2-microglobin gene (b2m). To ensure that our PCR
were sensitive enough to detect relatively low levels of viral DNA,
we applied a sensitivity assay as previously described [40]. The
sensitivity of detection of each herpes virus, reached 200 copies/
ml. PCR end products were analyzed on 1% agarose gel, stained
with ethidium bromide and the bands were visualized under a UV
transilluminator (260 nm). All gels were scanned (AlphaInnotech,
USA). Integrated density of the bands was used as a quantitate
parameter and was calculated by digital image analysis (Scion
Image, USA). Normalization of each herpesvirus-positive sample
was achieved by the ratio of the integration density of the viral
PCR band versus the corresponding density of the b2m gene. All
PCR products were subjected to direct sequencing, confirming the
specificity of the amplification products.
Isolation of BALF macrophages
For the isolation of BALF macrophages, fresh BALF was
obtained at room temperature (R/T) and passed through a
Millipore filter to isolate cells in suspension from debris and
mucus. To pellet cells, samples were centrifuged at 1,500 rpm for
five minutes at R/T. The supernatant was discarded and the cells
were resuspended in 4 ml RPMI medium, 20% FBS, 106
penicillin/streptomycin. The cells were counted in a Neubauer
haemocytometer, plated in 60 mm culture dishes and incubated at
37uC in a humidified incubator with 5% CO2. All samples were
divided between two 60 mm culture dishes while for microscopy
purposes, glass coverslips were placed in the dishes before the cells
were plated. Following observation using an inverted microscope,
the adhered cells (macrophages) remained in the incubator and the
medium was replaced every two days.
Table 5. The clinicopathological characteristics of the subjects.
Bronchoalveolar Lavage group
Characteristics controls IPF f-NSIP p value
Number 6 13 7
Age* 56.3365.47 70.6566.56 61.75614.82 p1 0.000; p2 0.008; p3 0.005
Gender (male/female)** 4/2 11/2 3/4 p1 0.012; p2 0.013; p3 0.008
Nonsmokers** 2 6 4 NS
Smokers** 4 3 2 NS
Ex-smokers** 0 4 1 NS
FEV1* 10766.96 79.2963.93 94614.54 p1 0.017; p2 NS; p3 NS
FVC* 103610.26 86.0664.44 101.75619.38 p1 NS; p2 NS; p3 NS
FEV1/FVC* 78.2565 84.4762.05 87.2564.05 p1 NS; p2 NS; p3 NS
DLCO* 96625 5466.41 7566.49 p1 NS; p2 NS; p3 0,045
KCO* 106622 54.0166.41 7566.49 P1 NS; p2 NS; p3 0,045
Cell culture group
Characteristics controls IPF p value
Number 3 4
Age* 7065.64 66.7563.9 p=0.000
Gender (male/female)** 3/0 3/1 NS
Nonsmokers** 3 2 NS
Smokers** 0 1 NS
Ex-smokers** 0 1 NS
FEV1* 100.460.8 84.7569.15 NS
FVC* 106.262.52 8167.31 NS
FEV1/FVC* 94.762.85 8362.79 NS
DLCO* 100611.05 53.2569.65 NS
KCO* 110610.69 61.568.66 NS
Values are expressed as means 6 SEM (standard error of the mean).
*t-test; P,0.05 is considered statistically significant.
**x
2 test; P,0.05 is considered statistically significant.
NS; not significant.
Abbreviations: FEV1: forced expiratory volume in one second, FVC: forced vital capacity, DLCO, diffusing capacity for carbon monoxide, KCO: DLCO per unit lung volume.
p1: P value between IPF and controls, p2: P value between f-NSIP and controls, p3: P value between IPF and f-NSIP.
doi:10.1371/journal.pone.0027800.t005
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immunofluorescence assay
Upon confluency of the primary culture, the cells were infected
with a wild-type HSV-1 strain 17+ at a multiplicity of infection
(MOI) 2. Each sample was either infected with HSV-1 or mock
infected, in a 60 mm culture dish. For the mock infections, the
medium used for the dilution of the virus was applied to the cells,
instead of the virus. The proportion of infected cells was
determined by immunofluorescence, counting the number of
fluorescence-positive cells in comparison to the total number of
cells in each sample. Infection of the cells at a multiplicity of
infection MOI=2 resulted in 80% infectivity by HSV-1.
At specific time points corresponding to the expression of
immediate-early, early and late HSV-1 genes (3 hours for ICP0,
8 hours for ICP8 and 15 hours for gG, respectively) the glass
coverslips from both Petri dishes were moved to 24-well culture
plates and proceeded for immunofluorescence staining, whereas
the remaining cells in the dishes were recovered with Trizol
reagent.
The glass coverslips were washed in PBS, fixed with 3.7%
formaldehyde in PBS containing 2% sucrose) and then permea-
bilized with 0.5% NP-40 in PBS with 10% sucrose. The coverslips
were incubated for one hour at room temperature with primary
antibodies for the HSV-1 ICP0, ICP8 and gG proteins
(SantaCruz, USA) diluted in PBS containing 1% fetal calf serum
and subsequently washed 3 times prior to incubation with a mouse
Alexa 488 secondary antibody (Molecular Probes, USA) under the
same conditions. Nuclei were stained with DAPI (4,6-diamidino-2-
phenylindole). The examination was performed using an epifluor-
escent Leica DMIRE2 microscope, equipped with a Leica
DFC300 FX digital camera. Camera image acquisition was
controlled by IM50 software (Leica). Single images were exported
as TIFF files from the IM50 software.
Gene expression
BALF pellets and cells from primary cultures (both mock and
HSV-1 infected) were processed using the Trizol reagent
(Invitrogen, Carlsbad, CA, USA) protocol for total RNA and
DNA extraction according to the manufacturer’s instructions.Prior
of RNA extraction, a proportion of the cells in suspension was
stained with Trypan Blue and then visually examined to determine
the percentage of viable cells. The vast majority of the cells,
approximately 95%, were viable. RNA concentration and purity
were evaluated by a spectrophotometer. Aliquots of RNA were
stored at 280uC until use. cDNA from each sample was derived
by reverse transcription of 2 mg of total RNA using the
AffinityScript
TM Multi Temperature cDNA synthesis kit, (Strata-
gene, La Jolla, CA, USA). Random hexamers were used as
amplification primers. To remove the RNA template, cDNA was
incubated with E. coli RNaseH, and stored at 220uC until use.
The expression of cellular genes was determined 24 hours post
infection, when the life cycle of HSV-1 is completed. Transcript
levels of SDF1a, SDF1b, VEGF, CXCR4, TGFb1, FGF, CCR7,
CCL19, CCL21, TLR3, TLR8, TLR9, MMP2 and MMP9 were
Table 6. Primer sequences used for quantitative Real-Time RT-PCR.
Gene Primer pair sequence (59-39) Annealing temperature
b-Actin FOR: CGGCATCGTCACCAACTG
REV: GGCACACGCAGCTCATTG
60uC
TLR-3 FOR:ACACCATCTATTAAAAGACCCATTAT
REV: TCCAGATTTTGTTCAATAGCTTGTT
62uC
TLR-8 FOR:GCTTTCTTTCTGAAGTCAGTAGTCT
REV:TTTCCGTGTAGTTCCAACATAGATAA
58uC
TLR-9 FOR:CTGAGTGAGAACTTCCTCTACAAATG
REV:TCTTTTGGTAATTGAAGGACAGGTTA
58uC
MMP2 FOR:CACGCTGGGCCCTCTCACTC
REV:GGGCCCTCGTATACCGCATCATTC
60uC
MMP9 FOR:GAGTGGCAGGGGGAAGATGC REV:CCTCAGGGCACTGCAGGATG 60uC
SDF-1a FOR: TGAGAGCTCGCTTTGAGTGA
REV: CACCAGGACCTTCTGTGGAT
55uC
SDF-1b FOR: CTAGTCAAGTGCGTCCACGA
REV: GGACACACCACAGCACAAAC
55uC
CXCR4 FOR: GGTGGTCTATGTTGGCGTCT
REV: TGGAGTGTGACAGCTTGGAG
55uC
FGF FOR: CTGGCTATGAAGGAAGATGGA
REV: TGCCCAGTTCGTTTCAGTG
55uC
TGF-b1 FOR:AAGGACCTCGGCTGGAAGTGC
REV: CCGGGTTATGCTGGTTGTA
62uC
CCL21 FOR:CCCAGGACCCAAGGCAGTGAT
REV:GGGGGGCAAGAAGGATAG
58uC
CCR7 FOR:GGTGGTGGCTCTCCTTGTCATTTT
REV:AGTTCCGCACGTCCTTCTT
55uC
CCL19 FOR:GGACTTCCCCAGCCCCAACTCT
REV:TAACTGCTGCGGCGCTTCATCTT
62uC
VEGF FOR: ATGACGAGGGCCTGGAGTGTG
REV:CCCTATGTGCTGGCCTTGGTGAG
60uC
doi:10.1371/journal.pone.0027800.t006
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gene) and SYBR Green I Master Mix (Stratagene, La Jolla, CA,
USA) according to the manufacturer’s instructions, as previously
described [41–44]. All primers were designed to span at least one
intron in order to avoid amplification of contaminating genomic
DNA. b-actin was used as an internal control to normalize mRNA
expression levels, as previously described [41]. To verify the results
of the melt curve analysis, PCR products were analyzed by
electrophoresis on 2% agarose gels stained with ethidium bromide
and photographed on a UV light transilluminator. Primer
sequences and annealing temperatures for all the genes analyzed,
as well as for b-actin are shown in Table 6.
Statistical analysis
The Kolmogorov-Smirnov test was used to determine whether
the expression data obtained follow a normal distribution pattern.
The mRNA expression of all genes was compared between the
groups of normal and pathological samples, as well as between
groups with different histological features using non-parametric
procedures (the Kruskal Wallis and Mann-Whitney tests). Paired t-
test (parametric analysis) was performed for the gene expression of
the primary cultures.
Probability values (P-values),0.05 were considered statistically
significant. Statistical calculations were performed using SPSS
11.5 software (SPSS, Chicago, IL, USA).
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